Nikkiso Co

Nikkiso Co Financial Leverage

The Financial Leverage (Equity Multiplier) of Nikkiso Co (6376.T) as of Oct 22, 2026 is 2.26. In the previous year, Financial Leverage (Equity Multiplier) was 2.32 — a change of -2.59% (lower).

Financial Leverage

2.26

YoY

-2.59%

Last updated:

Financial Leverage (Equity Multiplier) of Nikkiso Co is 2025 2.26 . Financial Leverage (Equity Multiplier) of Nikkiso Co was 2024 2.32 . It decreases by -2.59% lower compared to the previous year.

The Nikkiso Co Financial Leverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financial Leverage
Date
Financial Leverage
Jan 1, 2018
3.26 JPY
Jan 1, 2019
3.10 JPY
Jan 1, 2020
3.16 JPY
Jan 1, 2021
3.24 JPY
Jan 1, 2022
2.51 JPY
Jan 1, 2023
2.38 JPY
Jan 1, 2024
2.32 JPY
Jan 1, 2025
2.26 JPY
The Nikkiso Co Financial Leverage history
YEARFinancial LeverageYoY
2.26-2.59%
2.32-2.37%
2.38-5.11%
2.51-22.62%
3.24+2.57%
3.16+1.89%
3.10-4.82%
3.26-0.01%
3.26+21.89%
2.67+5.15%
2.54-5.91%
2.70—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Nikkiso Co Stock analysis

What does Nikkiso Co do? Nikkiso Co., Ltd. generates revenue through the manufacture, sale, and maintenance of industrial and medical equipment across two distinct business segments. The Industrial Business segment focuses on industrial special pumps, liquefied gas and industrial gas related equipment, as well as precision equipment, aerospace, and deep ultraviolet light emitting diode (LED) products. This segment serves customers requiring specialized industrial machinery and advanced technological components. The Medical Business segment drives income by producing and maintaining dialysis-related products such as artificial dialysis machines, dialyzers, blood circuits, and powder-type dialysis agents. Additionally, the company offers products and medicines for CRRT, artificial pancreas devices for blood glucose management, and energy devices for microwave surgery. These offerings cater to healthcare providers and patients requiring acute blood purification and chronic disease management solutions. Nikkiso Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Nikkiso Co stock

Financial Leverage (Equity Multiplier) of Nikkiso Co is 2.26 in 2025.

Financial Leverage (Equity Multiplier) of Nikkiso Co changed from 2.32 to 2.26, representing a -2.59% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Financial Leverage (Equity Multiplier) Nikkiso Co since 2006 – with annual values, charts, and detailed analysis.

Financial leverage, also known as the equity multiplier, measures total assets relative to equity. Higher leverage amplifies both returns and risks.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Financial Leverage (Equity Multiplier)'s Nikkiso Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Nikkiso Co

All Key Metrics — Nikkiso Co